Pages that link to "Q44336255"

The following pages link to Location of regions of the opioid receptor involved in selective agonist binding (Q44336255):

Displaying 35 items.

• Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors (Q33679621) (← links)
• Mutational analysis of the structure and function of opioid receptors (Q33910436) (← links)
• Structure and regulation of opioid receptors (Q34136307) (← links)
• A new cytokine: the possible effect pathway of methionine enkephalin (Q36506335) (← links)
• Modeling and simulation of the human delta opioid receptor (Q36519212) (← links)
• Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding (Q36851756) (← links)
• The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions (Q37208197) (← links)
• Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists (Q37550895) (← links)
• Recent advances in endomorphin engineering (Q37758621) (← links)
• Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE. (Q38322143) (← links)
• Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide (Q38360605) (← links)
• On the role of extracellular loops of opioid receptors in conferring ligand selectivity (Q40382141) (← links)
• 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors (Q40787493) (← links)
• Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. (Q40817051) (← links)
• Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists. (Q40950798) (← links)
• Intense pruritus in Epstein-Barr virus (EBV) hepatitis treated with naloxone drip (Q41517941) (← links)
• Cholesterol content drives distinct pharmacological behaviours of micro-opioid receptor in different microdomains of the CHO plasma membrane. (Q42439318) (← links)
• Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. (Q43557580) (← links)
• Interaction between morphine and lysine (Q43621525) (← links)
• Pharmacological profiles of selective non-peptidic delta opioid receptor ligands (Q44333416) (← links)
• Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ‐ and μ‐opioid receptors (Q44333522) (← links)
• Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain (Q44341260) (← links)
• The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor (Q44341533) (← links)
• Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition (Q44341639) (← links)
• Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands (Q44341996) (← links)
• Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor (Q44342010) (← links)
• Differential opioid agonist regulation of the mouse mu opioid receptor (Q44344713) (← links)
• Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking (Q44344899) (← links)
• Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods (Q44346651) (← links)
• Naloxone Activation of μ-Opioid Receptors Mutated at a Histidine Residue Lining the Opioid Binding Cavity (Q44347599) (← links)
• Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to mu receptors. (Q44350218) (← links)
• Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization (Q44351416) (← links)
• Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins (Q44351664) (← links)
• Molecular modeling study of the differential ligand-receptor interaction at the mu, delta and kappa opioid receptors (Q44352483) (← links)
• Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors (Q48939216) (← links)